Krähenbühl S[Author] - Search Results

Year	Number of Results
1981	1
1982	2
1986	1
1988	1
1989	3
1990	1
1991	5
1992	4
1993	6
1994	9
1995	11
1996	13
1997	11
1998	10
1999	5
2000	10
2001	8
2002	7
2003	10
2004	7
2005	11
2006	24
2007	18
2008	18
2009	12
2010	21
2011	12
2012	14
2013	15
2014	14
2015	14
2016	16
2017	23
2018	19
2019	35
2020	30
2021	4

1

Leucopenia associated with metamizole: a case-control study.

Blaser L, Hassna H, Hofmann S, Holbro A, Haschke M, Rätz Bravo A, Zeller A, Krähenbühl S, Taegtmeyer A. Blaser L, et al. Among authors: krahenbuhl s. Swiss Med Wkly. 2017 May 24;147:w14438. doi: 10.4414/smw.2017.14438. eCollection 2017. Swiss Med Wkly. 2017. PMID: 28634963 Free article.

2

Mechanisms of statin-associated skeletal muscle-associated symptoms.

Bouitbir J, Sanvee GM, Panajatovic MV, Singh F, Krähenbühl S. Bouitbir J, et al. Among authors: krahenbuhl s. Pharmacol Res. 2020 Apr;154:104201. doi: 10.1016/j.phrs.2019.03.010. Epub 2019 Mar 12. Pharmacol Res. 2020. PMID: 30877064 Review.

3

Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects.

Haschke M, Schuster M, Poglitsch M, Loibner H, Salzberg M, Bruggisser M, Penninger J, Krähenbühl S. Haschke M, et al. Among authors: krahenbuhl s. Clin Pharmacokinet. 2013 Sep;52(9):783-92. doi: 10.1007/s40262-013-0072-7. Clin Pharmacokinet. 2013. PMID: 23681967 Clinical Trial.

4

Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle.

Sanvee GM, Panajatovic MV, Bouitbir J, Krähenbühl S. Sanvee GM, et al. Among authors: krahenbuhl s. Biochem Pharmacol. 2019 Jun;164:23-33. doi: 10.1016/j.bcp.2019.02.025. Epub 2019 Feb 20. Biochem Pharmacol. 2019. PMID: 30796916

5

Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers.

Duthaler U, Suenderhauf C, Karlsson MO, Hussner J, Meyer Zu Schwabedissen H, Krähenbühl S, Hammann F. Duthaler U, et al. Among authors: krahenbuhl s. Br J Clin Pharmacol. 2019 Mar;85(3):626-633. doi: 10.1111/bcp.13840. Epub 2019 Jan 24. Br J Clin Pharmacol. 2019. PMID: 30566757 Free PMC article. Clinical Trial.

6

Dose adjustment in patients with liver disease.

Delcò F, Tchambaz L, Schlienger R, Drewe J, Krähenbühl S. Delcò F, et al. Among authors: krahenbuhl s. Drug Saf. 2005;28(6):529-45. doi: 10.2165/00002018-200528060-00005. Drug Saf. 2005. PMID: 15924505 Review.

7

Medikamentöse Hepatopathien.

Krähenbühl S, Pichler WJ. Krähenbühl S, et al. Ther Umsch. 2017 Jul;74(3):123-130. doi: 10.1024/0040-5930/a000895. Ther Umsch. 2017. PMID: 28777047 Review. German. No abstract available.

8

Effect of L-carnitine supplementation on the body carnitine pool, skeletal muscle energy metabolism and physical performance in male vegetarians.

Novakova K, Kummer O, Bouitbir J, Stoffel SD, Hoerler-Koerner U, Bodmer M, Roberts P, Urwyler A, Ehrsam R, Krähenbühl S. Novakova K, et al. Among authors: krahenbuhl s. Eur J Nutr. 2016 Feb;55(1):207-17. doi: 10.1007/s00394-015-0838-9. Epub 2015 Jan 23. Eur J Nutr. 2016. PMID: 25612929

9

Lifestyle-Medikamente: Vergnügen ohne Ende?

Krähenbühl S. Krähenbühl S. Ther Umsch. 2016 Nov;73(11):701-706. doi: 10.1024/0040-5930/a000853. Ther Umsch. 2016. PMID: 28276266 Review. German. No abstract available.

10

Role of PGC-1-alpha-associated Mitochondrial Biogenesis in Statin-induced Myotoxicity.

Panajatovic M, Singh F, Duthaler U, Krähenbühl S, Bouitbir J. Panajatovic M, et al. Among authors: krahenbuhl s. Eur Cardiol. 2020 May 15;15:e35. doi: 10.15420/ecr.2020.15.1.PO12. eCollection 2020 Feb. Eur Cardiol. 2020. PMID: 32612695 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results